Therapeutic tetrahydroisoquinoline-based compositions for cancer therapy
US8507523B2 · kind B2 · utility
0Cited by
0References
10Claims
0Family size
Inventors
Key dates
| Filing date | Nov 21, 2007 |
| Grant date | Aug 13, 2013 |
| Priority date | — |
| Expiry date | Dec 16, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D491/056
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Disclosed are therapeutic tetrahydroisoquinoline compositions for the treatment of cancer, these compositions having selectivity for cancer cells while demonstrating few, if any, deleterious side effects on normal cells.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.